ACS Global, Inc.
ACS Global, Inc. (AMCY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
amcy · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
ACS Global, Inc.You AMCY | $171M | N/A | — | — |
 Adocia S.A. ADOCY | $170M | N/A | — | -$0.81 |
 AnGes, Inc. AMGXF | $143M | N/A | — | -$14.45 |
 Broncus Holding Corporation BRNHF | $162M | N/A | — | -$0.03 |
 Cell MedX Corp. CMXC | $126M | N/A | — | -$0.03 |
 Diaceutics PLC DIUXF | $169M | 886.75x | +88.6% | $0.00 |
 EKF Diagnostics Holdings plc EKDHF | $168M | 53.81x | -88.6% | $0.00 |
Industry Average 2 peers with valid PE | — | 470.28x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for ACS Global, Inc. (AMCY) measures how much investors pay for each dollar of the company's trailing earnings. AMCY's current PE ratio of N/A is calculated by dividing its stock price of $3.00 by its TTM earnings per share of —.
Frequently asked questions
AMCY pe ratio · 6 questionsAMCY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.00 and TTM EPS of —. Data sourced from Financial Modeling Prep via AMCY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · ACS Global, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09